3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
323
Leukemia, Myeloid, Acute
276
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
244
Leukemia
116
Myeloproliferative Disorders
106
Primary Myelofibrosis
100
Precursor Cell Lymphoblastic Leukemia-Lymphoma
100
Leukemia, Myelomonocytic, Chronic
78
Polycythemia Vera
73
Hematologic Neoplasms
67
Multiple Myeloma
50
Neoplasms
41
Lymphoma, Non-Hodgkin
40
Thrombocythemia, Essential
39
Hematologic Diseases
38
Leukemia, Lymphocytic, Chronic, B-Cell
37
Recurrence
35
Lymphoma
32
Leukemia, Myeloid, Chronic-Phase
31
Mastocytosis, Systemic
26
Bone Marrow Diseases
25
Leukemia, Myeloid
23
Blast Crisis
23
Anemia, Refractory, with Excess of Blasts
23
Hodgkin Disease
21
Bronchiolitis Obliterans Syndrome
16
Mastocytosis
15
Philadelphia Chromosome
14
Leukemia, Mast-Cell
13
Graft vs Host Disease
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Metabolism, Inborn Errors
×
Myeloid
×
Clear all
NCT00596999
2012-04-10
HPDSC
Celgene
Unknown
6 enrolled